FINNENCE ▪ THE WIRE FILE
THE WIRE · № 79703
News■ Unclear/unknown
New Survey: 76% of People Say Health Care Is A Top Three Issue Determining Their Vote
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A survey on voter healthcare priorities hints at policy salience but no specific legislation or spending.
Healthcare ranks high for voters ahead of elections
CATALYST TO WATCH
Concrete healthcare legislation or pricing rules
MAIN RISK
Survey sentiment may not translate into policy
FULL DISPATCH
Additional findings reveal voters agree the health care system is broken, but are split on how to fix it: 48% want to see radical change while 52% prefer targeted, incremental improvements WASHINGTON, Oct. 14, 2026 /PRNewswire/ -- Today, United States of Care (USofCare) released their...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Senior Star Marks 50 Years and Earns FORTUNE Best Workplace Recognition2026-10-14 12:10 UTC
Senior Star Marks 50 Years and Earns FORTUNE Best Workplace Recognition2026-10-14 12:10 UTC
→CORRELATIONshares Healthcare
ROMTech Wins Newsweek 2026 AI Impact Health Award for AI-Enabled Remote Patient Monitoring2026-10-14 12:17 UTC
ROMTech Wins Newsweek 2026 AI Impact Health Award for AI-Enabled Remote Patient Monitoring2026-10-14 12:17 UTC
→CORRELATIONshares Healthcare
NYC & Global Walk - 2026 FINAL Walk with Us to Cure Lupus Returns to New York City and Around the World on October 242026-10-14 12:28 UTC
NYC & Global Walk - 2026 FINAL Walk with Us to Cure Lupus Returns to New York City and Around the World on October 242026-10-14 12:28 UTC
→CORRELATIONshares Healthcare
New Phase 3 trial: A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis — Almirall, S.A.2026-10-14 12:00 UTC
New Phase 3 trial: A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis — Almirall, S.A.2026-10-14 12:00 UTC
→CORRELATIONshares Healthcare
Phase 3 results posted: A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome — Hoffmann-La Roche2026-10-14 12:00 UTC
Phase 3 results posted: A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome — Hoffmann-La Roche2026-10-14 12:00 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.